Natural Products in Liver Fibrosis Management: A Five-year Review

被引:0
作者
Wang, Tao [1 ,2 ]
Lu, Zhuo [3 ]
Sun, Gui-Feng [1 ,2 ]
He, Kai-Yi [1 ,2 ]
Chen, Zhi-Ping [2 ,5 ]
Qu, Xin-Hui [2 ,4 ]
Han, Xiao-Jian [1 ,2 ,4 ]
机构
[1] Jiangxi Prov Peoples Hosp, Inst Geriatr, Nanchang 330006, Jiangxi, Peoples R China
[2] Nanchang Med Coll, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China
[3] Nanchang Univ, Affiliated Hosp 1, Dept Thorac Surg, Nanchang 330006, Jiangxi, Peoples R China
[4] Jiangxi Prov Peoples Hosp, Dept Neurol 2, Nanchang 330006, Jiangxi, Peoples R China
[5] Jiangxi Prov Peoples Hosp, Dept Crit Care Med, Nanchang 330006, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Liver fibrosis; hepatic stellate cell; etiology; antifibrosis; molecular mechanism; natural product; immune cells; HEPATIC STELLATE CELLS; TGF-BETA; PDGF; DISEASE; HMGB1; PROLIFERATION; INFLAMMATION; APOPTOSIS; COLLAGEN; RISK;
D O I
10.2174/0109298673288458240203064112
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Liver fibrosis, characterized by the overproduction of extracellular matrix proteins within liver tissue, poses a rising global health concern. However, no approved antifibrotic drugs are currently available, highlighting the critical need for understanding the molecular mechanisms of liver fibrosis. This knowledge could not only aid in developing therapies but also enable early intervention, enhance disease prediction, and improve our understanding of the interaction between various underlying conditions and the liver. Notably, natural products used in traditional medicine systems worldwide and demonstrating diverse biochemical and pharmacological activities are increasingly recognized for their potential in treating liver fibrosis. This review aims to comprehensively understand liver fibrosis, emphasizing the molecular mechanisms and advancements in exploring natural products' antifibrotic potential over the past five years. It also acknowledges the challenges in their development and seeks to underscore their potency in enhancing patient prognosis and reducing the global burden of liver disease.
引用
收藏
页码:5061 / 5082
页数:22
相关论文
共 130 条
  • [1] The Hepatoprotective Effect of Piperine Against Thioacetamide-Induced Liver Fibrosis in Mice: The Involvement of miR-17 and TGF-β/Smads Pathways
    Abdelhamid, Amr M.
    Selim, Ayman
    Zaafan, Mai A.
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [2] Lycorine Ameliorates Thioacetamide-Induced Hepatic Fibrosis in Rats: Emphasis on Antioxidant, Anti-Inflammatory, and STAT3 Inhibition Effects
    Alkreathy, Huda Mohammed
    Esmat, Ahmed
    [J]. PHARMACEUTICALS, 2022, 15 (03)
  • [3] Proanthocyanidins attenuated liver damage and suppressed fibrosis in CCl4-treated rats
    Amer, Maher A.
    Othman, Azza, I
    El-Missiry, Mohamed A.
    Farag, Aya A.
    Amer, Maggie E.
    [J]. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2022, 29 (60) : 91127 - 91138
  • [4] Fibrogenic polymorphisms (TGF-β, PAI-1, AT) in Mexican patients with established liver fibrosis.: Potential correlation with Pirfenidone treatment
    Armendariz-Borunda, Juan
    Rosa Rincon, Ana
    Francisco Munoz-Valle, Jose
    Bueno-Topete, Miriam
    Oregon-Romero, Edith
    Cristina Islas-Carbajal, Maria
    Medina-Preciado, David
    Gonzalez-Garcia, Ignacio
    Alfredo Bautista, C.
    Garcia-Rocha, Sergio
    Godoy, Jesus
    Vazquez-Del Mercado, Monica
    Troyo-SanRoman, Rogelio
    Arellano-Olivera, Inmaculada
    Lucano, Silvia
    Alvarez-Rodriguez, Adriana
    Salazar, Adriana
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (07) : 944 - 953
  • [5] The behavior of some chalcones on acetylcholinesterase and carbonic anhydrase activity
    Aslan, Hatice Esra
    Demir, Yeliz
    ozaslan, Muhammet Serhat
    Turkan, Fikret
    Beydemir, Sukru
    Kufrevioglu, Omer Irfan
    [J]. DRUG AND CHEMICAL TOXICOLOGY, 2019, 42 (06) : 634 - 640
  • [6] Aucubin ameliorates liver fibrosis and hepatic stellate cells activation in diabetic mice via inhibiting ER stress-mediated IRE1α/TXNIP/NLRP3 inflammasome through NOX4/ROS pathway
    Bao, Xiaowen
    Li, Jiaqi
    Ren, Chaoxing
    Wei, Jingxun
    Lu, Xuanzhao
    Wang, Xiaoxuan
    Du, Wei
    Jin, Xin
    Ma, Beiting
    Zhang, Qi
    Ma, Bo
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 365
  • [7] Purification of Polyphenol Oxidase from Potato and Investigation of the Inhibitory Effects of Phenolic Acids on Enzyme Activity
    Bayrak, Songul
    Ozturk, Cansu
    Demir, Yeliz
    Alim, Zuhal
    Kufrevioglu, Omer Irfan
    [J]. PROTEIN AND PEPTIDE LETTERS, 2020, 27 (03) : 187 - 192
  • [8] Liver fibrosis: Pathophysiology and clinical implications
    Berumen, Jennifer
    Baglieri, Jacopo
    Kisseleva, Tatiana
    Mekeel, Kristin
    [J]. WIRES MECHANISMS OF DISEASE, 2021, 13 (01):
  • [9] Isoniazid and Rifampicin Produce Hepatic Fibrosis through an Oxidative Stress-Dependent Mechanism
    Biswas, Ayan
    Santra, Suman
    Bishnu, Debasree
    Dhali, Gopal Krishna
    Chowdhury, Abhijit
    Santra, Amal
    [J]. INTERNATIONAL JOURNAL OF HEPATOLOGY, 2020, 2020
  • [10] LIVER-CELL HETEROGENEITY - FUNCTIONS OF NONPARENCHYMAL CELLS
    BOUWENS, L
    DEBLESER, P
    VANDERKERKEN, K
    GEERTS, B
    WISSE, E
    [J]. ENZYME, 1992, 46 (1-3) : 155 - 168